Page 4 - Gloria Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gilead and Arcus Announce Amended Collaboration and Equity Investment

Gilead and Arcus Announce Amended Collaboration and Equity Investment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Foster cityUnited statesJohanna mercierMerdad parseyJacquie rossMeaghan smithTerry rosenHolli kolkeyGuangzhou gloria biosciences coArcus biosciences incExchange commissionGilead sciences incGilead sciencesInvestment reinforces companie convictionProvides opportunityAdditional equity investment

BioLineRx: Still A Buy, With Some Questions (NASDAQ:BLRX)

BioLineRx: Still A Buy, With Some Questions (NASDAQ:BLRX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesGloria biosciencesConference in pancreatic cancer researchEgg embryosPancreatic cancerGuangzhou gloria biosciences

BioLineRx: Weighing Aphexda s Breakthrough Against Financial Challenges (NASDAQ:BLRX)

BioLineRx: Weighing Aphexda s Breakthrough Against Financial Challenges (NASDAQ:BLRX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Tel avivGloria biosciencesTel aviv stock exchangeBiolinerx ltdWashington university in stInnovative pharmaceutical concepts incColumbia universityWashington universityPancreatic cancerBiolinerx corporateExpanding motixafortide

Coherus prices China-made PD-1 at 20% discount to Keytruda

Coherus prices China-made PD-1 at 20% discount to Keytruda
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Coherus biosciencesDenny lanfearGloria biosciencesEli lillyFosun pharmaJunshi biosciencesMerck coInnovent biologics partnered tyvytArcus biosciencesWuxi biologicsShanghai henlius

BioLineRx Ltd (NASDAQ:BLRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Third Quarter 2023 Financial Results Conference Call. All participants are presently in a listen-only mode.

United statesGloria biosciencesJoe pantginisElla soraniPhil serlinJohn laceyColumbia universityUs researchOil producing countriesExchange commissionCorporate communicationsAmerican societyWashington university school of medicineBiolinerx ltdCall transcript novemberBiolinerx third quarter